Novel drug targets in clinical development for heart failure.

Item

http://www.wikidata.org/entity/Q38202895

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel drug targets in clinical development for heart failure.

@en

type

Item

label

Novel drug targets in clinical development for heart failure.

@en

prefLabel

Novel drug targets in clinical development for heart failure.

@en

P1476

Novel drug targets in clinical development for heart failure

@en

P2093

Elangovan Shanmugam

http://www.w3.org/2001/XMLSchema#string

Muthukumar Rajaram

http://www.w3.org/2001/XMLSchema#string

Thangavel Mahalingam VijayaKumar

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

Epidemiology and risk profile of heart failure

Relaxin: review of biology and potential role in treating heart failure.

Cardiac myosin activation part 1: from concept to clinic.

Roles of atrial natriuretic peptide and its therapeutic use.

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

The ryanodine receptor in cardiac physiology and disease.

P2888

s00228-014-1671-4

P304

765-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-014-1671-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melvin George

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030236637

http://www.w3.org/2001/XMLSchema#string

P698

24710739

http://www.w3.org/2001/XMLSchema#string

P921

heart failure